Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Marco Kaltofen, Keeve E. Nachman & Dale Hattis. (2020) Letter concerning: Clewell (2019) incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene. Inhalation Toxicology 32:8, pages 327-327.
Read now
Read now
Articles from other publishers (10)
J. L. CampbellJr.Jr., H. J. ClewellIIIIII, C. Van Landingham, P. R. Gentry & M. E. Andersen. (2023) Using available in vitro metabolite identification and time course kinetics for β-chloroprene and its metabolite, (1-chloroethenyl) oxirane, to include reactive oxidative metabolites and glutathione depletion in a PBPK model for β-chloroprene. Frontiers in Pharmacology 14.
Crossref
Crossref
Rebecca A. Clewell & Harvey J. ClewellIIIIII. 2003. Patty's Toxicology. Patty's Toxicology
1
18
.
Constance A. Mitchell, Natalie Burden, Mark Bonnell, Markus Hecker, Thomas H. Hutchinson, Magdalena Jagla, Carlie A. LaLone, Laurent Lagadic, Scott G. Lynn, Bryon Shore, You Song, Sara M. Vliet, James R. Wheeler & Michelle R. Embry. (2023) New Approach Methodologies for the Endocrine Activity Toolbox: Environmental Assessment for Fish and Amphibians. Environmental Toxicology and Chemistry 42:4, pages 757-777.
Crossref
Crossref
Rory P. Conolly, Harvey J. Clewell, Martha M. Moore, Jerry L. Campbell, Wanyun Cheng & R. Robinan Gentry. (2023) PBPK modeling to evaluate maximum tolerated doses: A case study with 3-chloroallyl alcohol. Frontiers in Pharmacology 14.
Crossref
Crossref
Laura N. Vandenberg, Swati D. G. Rayasam, Daniel A. Axelrad, Deborah H. Bennett, Phil Brown, Courtney C. Carignan, Nicholas Chartres, Miriam L. Diamond, Rashmi Joglekar, Bhavna Shamasunder, Kristin Shrader-Frechette, Wilma A. Subra, Ken Zarker & Tracey J. Woodruff. (2023) Addressing systemic problems with exposure assessments to protect the public’s health. Environmental Health 21:S1.
Crossref
Crossref
Marjory Moreau, Jeff Fisher, Melvin E. Andersen, Asayah Barnwell, Sage Corzine, Aarati Ranade, Patrick D. McMullen & Scott D. Slattery. (2022) NAM-based prediction of point-of-contact toxicity in the lung: A case example with 1,3-dichloropropene. Toxicology 481, pages 153340.
Crossref
Crossref
Xiaoqing Chang, Yu-Mei Tan, David G. Allen, Shannon Bell, Paul C. Brown, Lauren Browning, Patricia Ceger, Jeffery Gearhart, Pertti J. Hakkinen, Shruti V. Kabadi, Nicole C. Kleinstreuer, Annie Lumen, Joanna Matheson, Alicia Paini, Heather A. Pangburn, Elijah J. Petersen, Emily N. Reinke, Alexandre J. S. Ribeiro, Nisha Sipes, Lisa M. Sweeney, John F. Wambaugh, Ronald Wange, Barbara A. Wetmore & Moiz Mumtaz. (2022) IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making. Toxics 10:5, pages 232.
Crossref
Crossref
Kaixiang Zhou, Kun Mi, Wenjin Ma, Xiangyue Xu, Meixia Huo, Samah Attia Algharib, Yuanhu Pan, Shuyu Xie & Lingli Huang. (2021) Application of physiologically based pharmacokinetic models to promote the development of veterinary drugs with high efficacy and safety. Journal of Veterinary Pharmacology and Therapeutics 44:5, pages 663-678.
Crossref
Crossref
Melvin E. Andersen, Pankajini Mallick, Harvey J. ClewellIIIIII, Miyoung Yoon, Geary W. Olsen & Matthew P. Longnecker. (2021) Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures. Environmental Research 197, pages 111183.
Crossref
Crossref
Sonja N Sax, P. Robinan Gentry, Cynthia Van Landingham, Harvey J. Clewell & Kenneth A. Mundt. (2019) Extended Analysis and Evidence Integration of Chloroprene as a Human Carcinogen. Risk Analysis 40:2, pages 294-318.
Crossref
Crossref